Table S4.
Treatment response rates of bevacizumab and photodynamic therapy for the treatment of age-related macular degeneration
| Author | Year | Definition of treatment response | IVB | PDT | RR (95% CI) | ||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| No of responses | No of nonresponses | No of responses | No of nonresponses | ||||
| Lazic and Gabric20 | 2007 | 0.2 increase in logMAR | 1 | 53 | 0 | 50 | 2.78 (0.12–66.75) |
| Bashshur et al19 | 2007 | 3rd-line increase in Snellen fraction | 16 | 16 | 5 | 25 | 3.00 (1.25–7.17) |
| Sacu et al22 | 2009 | 15-letter increase in ETDRS score | 4 | 10 | 1 | 13 | 4.00 (0.51–31.46) |
| Parodi et al21 | 2010 | 15-letter increase in ETDRS score | 7 | 12 | 1 | 17 | 6.63 (0.90–48.69) |
| Pooled RR (95% CI) | 3.44 (1.67–7.1) | ||||||
Abbreviations: CI, confidence interval; IVB, intravitreal bevacizumab; PDT, photodynamic therapy; RR, relative risk; ETDRS, Early Treatment Diabetic Retinopathy Study; logMAR, logarithm of the minimum angle of resolution.